Research and development • APITER

We use our own and third-party cookies to collect information that helps optimize your experience on our website. Cookies will not be used to collect personal information. You can allow its use or reject it. You will find more information in our cookies policy.

Committed to research, innovation
and development of products of the highest
quality for the benefit of health


Research and development

From its beginnings Apiter Laboratories has been dedicated to research and development of technology related to farming, processing and formulation of Propolis to achieve traceability and stability of its active ingredients.

Seeing the value of this product for its health benefits, Apiter Laboratories pioneered awareness of Propolis collection for beekeepers of the region who used to discard it as a subproduct during cleaning and maintenance of beehives. Apiter also implemented natural Propolis farming with specially designed nets for bees to deposit the majority of their Propolis production, obtaining a fresh, less contaminated product with higher polyphenols concentration.

With the commitment to research and develop formulations to leverage the therapeutic benefits of this natural resource, in 1980 Apiter Laboratories launches in the Uruguayan market the first line of Propolis based pharmaceutical products, unprecedented at a regional and international level. Apiter's leadership in this field of pharmaceutical industry gained recognition in the Expo-Sevilla’92 as an Innovating Company from Uruguay amongst the 100 top innovating companies in Latin America.

Concurrently, for more than 10 years Apiter maintained an academic and technological exchange with the Universities of Tamagawa and Shizuoka in Japan, regarding the properties and composition of Uruguayan Propolis.

After this, strategic alliances were established with the faculty of Science and Chemistry of the National University and the Technological Pole of Pando, as well as with analysis laboratories from New Zealand and Germany, furthering the study and formulation of Propolis extract to obtain a standardized produce capable of meeting the pharmaceutical qualities and requirements of international markets.

Research and development of technology that involves interaction with these organizations is part of a High Impact Innovation Project approved by the National Agency for Research and Innovation (ANII). This project also involves a engineering of the company products and processes that begins by qualifying and certifying the beekeeper producers, pioneering a quality management program unprecedented in Uruguay that ensures a traceability criteria.

Beyond technological advances, this initiative goes further than the company, improving productivity and quality of all beehive products.

In reference to this project, Apiter Laboratories was awarded the Nova Prize 2010 for its innovation on the development of pharmaceutical quality Propolis extract, recognizing its social and economical impact, and the knowledge contribution that flows through its products to the rest of the world.